This bill, the Prescription Information Modernization Act of 2025, seeks to allow FDA-approved drug prescribing information to be made available solely through electronic means , amending the Federal Food, Drug, and Cosmetic Act. However, manufacturers must still provide prescribers and dispensers the option to receive paper copies upon request, promptly and without additional cost. The Department of Health and Human Services is directed to issue final regulations within one year to implement this digital communication, ensuring instructions are provided for requesting paper copies and that adverse economic impacts on healthcare professionals are minimized. Additionally, the Secretary must hold a public workshop within two years to discuss optimizing the format, accessibility, and usability of prescribing information.